Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors

NCT00053352 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00053352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 3, 2003
Completion date
June 30, 2021
Enrollment
302 (actual)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

childhood embryonal tumor, childhood extracranial germ cell tumor, childhood extragonadal germ cell tumor, childhood malignant ovarian germ cell tumor, childhood malignant testicular germ cell tumor, childhood teratoma, ovarian embryonal carcinoma, ovarian yolk sac tumor, stage ii malignant testicular germ cell tumor, stage iia ovarian germ cell tumor, stage iib ovarian germ cell tumor, stage iic ovarian germ cell tumor, stage iii malignant testicular germ cell tumor, stage iiia ovarian germ cell tumor, stage iiib ovarian germ cell tumor, stage iiic ovarian germ cell tumor, testicular choriocarcinoma and yolk sac tumor, testicular embryonal carcinoma